Literature DB >> 10408397

Ribozyme inhibition of the protein kinase C alpha triggers apoptosis in glioma cells.

M Leirdal1, M Sioud.   

Abstract

Although protein kinase C has been shown to be involved in a wide range of biological functions, the precise role of each isoform in a specific cell function remains to be clarified. Here we demonstrate that a ribozyme specific for the human protein kinase C alpha (PKC alpha), a classical PKC isoform, induces cell death in glioma cell lines. This cell death was identified as apoptosis by morphologic alterations and endonucleosomal DNA fragmentation. The inhibition of PKC alpha gene expression by the ribozyme resulted in a significant reduction in Bcl-xL gene expression, a protein that inhibits apoptosis and is overexpressed in glioma cells. Taken together, our data suggest that the PKC alpha ribozymes are a potent inducer of apoptosis in glioma cells, which may act through suppressing Bcl-xL gene expression and/or activity. PKC alpha ribozymes may prove useful in the management of malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408397      PMCID: PMC2363167          DOI: 10.1038/sj.bjc.6690560

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

Review 1.  Apoptosis and disease: regulation and clinical relevance of programmed cell death.

Authors:  C M Rudin; C B Thompson
Journal:  Annu Rev Med       Date:  1997       Impact factor: 13.739

2.  Simple RNA enzymes with new and highly specific endoribonuclease activities.

Authors:  J Haseloff; W L Gerlach
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Loss of protein kinase C function induces an apoptotic response.

Authors:  R D Whelan; P J Parker
Journal:  Oncogene       Date:  1998-04-16       Impact factor: 9.867

Review 5.  Protein kinase C--a family affair.

Authors:  P J Parker; G Kour; R M Marais; F Mitchell; C Pears; D Schaap; S Stabel; C Webster
Journal:  Mol Cell Endocrinol       Date:  1989-08       Impact factor: 4.102

Review 6.  Protein kinase C: a worthwhile target for anticancer drugs?

Authors:  F Caponigro; R C French; S B Kaye
Journal:  Anticancer Drugs       Date:  1997-01       Impact factor: 2.248

7.  A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia.

Authors:  L Pegoraro; A Palumbo; J Erikson; M Falda; B Giovanazzo; B S Emanuel; G Rovera; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis.

Authors:  P P Ruvolo; X Deng; B K Carr; W S May
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

9.  A nuclease-resistant protein kinase C alpha ribozyme blocks glioma cell growth.

Authors:  M Sioud; D R Sørensen
Journal:  Nat Biotechnol       Date:  1998-06       Impact factor: 54.908

10.  Ribozyme mediated destruction of RNA in vivo.

Authors:  M Cotten; M L Birnstiel
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  11 in total

Review 1.  Protein kinase C inhibitors.

Authors:  Helen C Swannie; Stanley B Kaye
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

Review 2.  Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Lars Rönnstrand
Journal:  Med Oncol       Date:  2013-10-31       Impact factor: 3.064

3.  Combination of endostatin and a protein kinase Calpha DNA enzyme improves the survival of rats with malignant glioma.

Authors:  Dag R Sorensen; Marianne Leirdal; Per Ole Iversen; Mouldy Sioud
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

4.  Selection, design, and characterization of a new potentially therapeutic ribozyme.

Authors:  Shawn P Zinnen; Kristal Domenico; Mike Wilson; Brent A Dickinson; Amber Beaudry; Victor Mokler; Andrew T Daniher; Alex Burgin; Leonid Beigelman
Journal:  RNA       Date:  2002-02       Impact factor: 4.942

Review 5.  Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas.

Authors:  A Besson; V W Yong
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

6.  ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.

Authors:  Jing-Shan Tong; Qing-Hua Zhang; Zhen-Bo Wang; Sen Li; Cai-Rong Yang; Xue-Qi Fu; Yi Hou; Zhao-Yi Wang; Jun Sheng; Qing-Yuan Sun
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

7.  Protein kinase C-dependent control of Bcl-x alternative splicing.

Authors:  Timothée Revil; Johanne Toutant; Lulzim Shkreta; Daniel Garneau; Philippe Cloutier; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

8.  Catalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: Review Article.

Authors:  Richard Tritz; Cellia Habita; Joan M Robbins; German G Gomez; Carol A Kruse
Journal:  Gene Ther Mol Biol       Date:  2005

Review 9.  The complexities of PKCα signaling in cancer.

Authors:  Adrian R Black; Jennifer D Black
Journal:  Adv Biol Regul       Date:  2020-11-23

10.  New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids.

Authors:  O A Patutina; N L Mironova; V V Vlassov; M A Zenkova
Journal:  Acta Naturae       Date:  2009-07       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.